home contact us  

2007 Faculty

Peter Libby, M.D. – Program co-chair
Mallinckrodt Professor of Medicine
Harvard Medical School and
Chief Cardiovascular Medicine,
Brigham and Women’s Hospital
Boston, MA

Jean-Claude Tardif, M.D. – Program co-chair
Director, Research Center
Professor of Medicine
CIHR Chair in Atherosclerosis
Montreal Heart Institute
Montreal, Quebec

Eric Abadie, M.D.
Director, Therapeutics Evaluation, AFSSAPS
European Medicines Agency (EMEA)
Paris, France

Christine Albert, M.D., MPH
Director, Center for Arrhythmia Prevention
Harvard Medical School
Boston, MA

Naomi Aronson, Ph.D.
Executive Director
Technology Evaluation Center
Blue Cross and Blue Shield Association
Chicago, IL

Robert S. Balaban, M.D., Ph.D.
Scientific Director
National Heart, Lung and Blood Institute National Institutes of Health
Bethesda, MD

Colin Berry, BSc., M.D., Ph.D.
Cardiovascular MRI / CV Intervention Program
NHLBI, National Institutes of Health
Bethesda, MD

Eric P. Brass, M.D., Ph.D.
Professor of Medicine
Harbor-UCLA Medical Center
Torrance, CA

W. Virgil Brown, M.D.
Charles Howard Candler Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Robert M. Califf, M.D.
Vice Chancellor for Clinical Research
Director, Duke Translational Medicine Institute
Durham, NC

Gao Chenyan, M.D.
Director of Division VII
Center of Drug Evaluation, China SFDA
Beijing, China

Jean Davignon, M.D.
Director Hyperlipidemia and Athero Research
Clinical Research Institute of Montreal
Professor of Medicine, University of Montreal
Montreal, Quebec

James De Lemos, M.D.
Associate Professor and CCU Director
University of Texas-Southwestern Medical School
Dallas, TX

Zahi A. Fayad, Ph.D.
Professor, Departments of Radiology and Medicine Mount Sinai School of Medicine
New York, NY

Felix W. Frueh, Ph.D.
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Alan J. Garber, M.D., Ph. D.
Professor, Medicine, Biochemistry,
Molecular and Cellular Biology
Baylor College of Medicine
Houston, TX

Federico Goodsaid, Ph.D.
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, MD

Steven Gutman, M.D.
Director, Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiologic Health, FDA
Silver Spring, MD

Rory Hachamovitch, M.D.
Department of Medicine
University of Southern California
Los Angeles, CA

Therese Heinonen, D.V.M.
Associate Director, Medical and
Scientific Affairs
Montreal Heart Institute
Montreal, Quebec Canada

Agnes Klein, M.D.
Director, Center for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate
Health Products and Food Branch,
Health Canada
Ottawa, Ontario

Daniel Levy, MD
Director, Framingham Heart Study
Director, Center for Population Studies
National Heart, Lung, & Blood Institute
Bethesda, MD

Elizabeth Mansfield, Ph.D.
Senior Policy Analyst
Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health
US Food and Drug Administration
Rockville, MD

Bruce McManus, M.D., Ph.D.
Professor and Director, The James Hogg iCAPTURE Centre
University of British Columbia - St. Paul's Hospital
Scientific Director, The Heart Centre - Providence Health Care
Vancouver, British Columbia

David O. Meltzer, M.D., Ph.D.
Director of the Center for Health and Social Sciences
Department of Medicine and Dept. of Economics
University of Chicago
Chicago, IL

George A. Mensah, M.D.
Chief Medical Officer,
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention
Atlanta, GA

Christopher O'Donnell, M.D.
Senior Advisor to the Director for Genome Research Associate Director
of the Framingham Heart Study
NHLBI, National Institutes of Health
Bethesda, MD

Mary Parks, M.D.
Division of Metabolism and Endocrine Products
Center for Drug Evaluation and Research
US Food and Drug Administration
Silver Spring, MD

Marc Pfeffer, M.D., Ph.D.
Professor of Medicine
Harvard Medical School
Boston, MA

Michael S. Phillips, Ph.D.
Director of Pharmacogenomics
Genome Quebec
Montreal, Quebec

Robert Powell, PharmD
Director, Pharmacometrics
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
US Food and Drug Administration
Silver Spring, MD

Gurvaneet Randhawa, M.D.
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality
Silver Spring, MD

Paul M. Ridker, M.D.
Eugene Braunwald Professor of
Medicine
Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, MA

John Rioux, Ph.D.
The Laboratory of Genetics and
Genomic Medicine of Inflammation
Université de Montréal and Montreal Heart Institute
Montreal, Quebec

Ernst Schaefer, M.D.
Director, Lipid Metabolism Laboratory
Tufts University
Boston, MA

Daniel Schultz, M.D.
Director, Center for Devices and Radiological Health
US Food and Drug Administration
Rockville, MD

David Smalley, Ph.D.
Assistant Professor Cardiovascular Research Center
University of Virginia

J. David Spence, M.D.
Director, Stroke Prevention and
Athero Research Centre
Robarts Research Institute
London, Ontario, CANADA

Norman Stockbridge, M.D.
Division of Cardio-Renal Drug Products
Center for Drug Evaluation and Research
US Food and Drug Administration
Silver Spring, MD

 

Allen Taylor, M.D.
Chief, Cardiology Service
Walter Reed Army Medical Center
Washington, DC

Douglas C. Throckmorton, M.D.
Deputy Center Director
Center for Drug Evaluation and Research
US Food and Drug Administration
Rockville, MD

Paula R. Trumbo, Ph.D.
Team Leader, Nutrition Science Evaluation
Center for Food Safety and Applied Nutrition
US Food and Drug Administration
College Park, MD

David Waters, M.D.
Chief, Cardiovascular Medicine
University of California
San Francisco, CA

Ralph Weissleder, M.D., Ph.D.
Director, Center for Molecular Imaging Research
Professor of Radiology, Harvard Medical School
Boston, MA

Bram Zuckerman, M.D.
Director, FDA Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health (CDRH)

INDUSTRY FACULTY INCLUDE

Jonathan Allis, Ph.D.
Global Head, Imaging Technology
General Electric Healthcare

Donald M. Black, MBA, M.D.
Global Head of Research & Develpment
General Electric Healthcare

Douglas Cowart, Pharm.D.
Association of Clinical Research Organizations

Giora Feuerstein, M.D.
Assistant Vice President
Head, Discovery Translational Medicine
Wyeth Research

Jean-Jacques Garaud, M.D.
Head of Global Drug Development
F. Hoffmann-La Roche Ltd

Seigo Izumo, M.D., Ph.D.
Vice President and Global Head CV Research
Novartis Institute for Biomedical Research

Michael Klimas, Ph.D.
Executive Director, Imaging Franchise Lead
Merck & Co., Inc.

Michele Mercuri, M.D., Ph.D.
VP and Global Head Pharma Scientific Review Committee
Novartis Pharmaceuticals Corp.

Gary F. Mitchell, M.D.
Cardiovascular Engineering, Inc.
Waltham, MA

Vincent Mooser, M.D.
Clinical Pharmacology and Disc. Med.
GlaxoSmithKline

David G. Orloff, M.D.
Medical Director
Medpace, Inc.

Michael Perelman, M.D.
Vice President, Global Project Mgmt
Schering-Plough Research Institute

Joel Raichlen, M.D.
Senior Director, Clinical Research
AstraZeneca

Amy E. Rudolph, Ph.D.
Clinical Director
Global Medical CV Metabolic Endocrine
Pfizer, Inc

William J. Sasiela, Ph.D.
Chief Medical Officer
Aegerion Pharmaceuticals, Inc.

John Wagner, MD, Ph.D.
Director, Clinical Pharmacology
Merck & Co., Inc.

G. Russell Warnick, M.S., MBA
Chief Scientific Officer
Berkeley HeartLab, Inc.

James J. Zhang, M.D., Ph..D., MBA
Global Clinical Development
Siemens Molecular Imaging, Inc
Siemens Medical Solutions USA 

ver. 11.17.07

 

"Building partnerships that lead to innovation and better patient outcomes."
828 W. Grand River Ave, Brighton, MI 48116
Phone: 810.494.7193 Fax: 810.494.7122
Powered by AlliedMedia.net

Critical Markers of Disease Critical Markers of Disease